Navigation Links
Intelligent Implant Systems Announces 510(k) Clearance of the Marauder Cervical-Thoracic Spinal System
Date:11/7/2013

Charlotte, NC (PRWEB) November 07, 2013

Intelligent Implant Systems, LLC, a recognized innovator in the treatment of spine disorders and development of spinal implant technology, announced today that the Marauder™ Cervical-Thoracic Spinal System was cleared by the FDA for sale in the United States. The Marauder™ Spinal System utilizes an advanced locking system that requires no torque or set screws and provides numerous benefits to the surgeon and patient. The design allows easier rod reduction as the screw head will temporarily remain where positioned to ease rod reduction. After rod reduction is complete, the implant is locked into its final position with a locking cap using an elegant, one-handed instrument. Intelligent Implant Systems recently exhibited this product at the NASS show in New Orleans, and the company is expanding the system and adding additional components which utilize the same patent pending technology for locking.

The Cervical-Thoracic Spinal System polyaxial screws are available in diameters of 3.5 and 4.0 mm. In addition, hooks are available, which, like the polyaxial screws, attach to a 3.5 mm rod and use the same torque-less technology for locking.

“We are pleased to announce clearance to market the Marauder™ Cervical-Thoracic system in the U.S.,” said Marc Richelsoph, President and CEO of Intelligent Implant Systems. “This addition to our product line expands our product portfolio, and along with planned implant additions, will provide a state-of-the-art system to treat the entire posterior spine. We additionally intend to incorporate this system with our exclusive Active™ Screw system to provide surgeons and patients a superior fixation option.”

Read the full story at http://www.prweb.com/releases/2013/11/prweb11305053.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Finesse Solutions Introduces SmartParts for Intelligent Universal Controllers
2. Regenetek Research Inc. Launches New Intelligent Software for Therapeutic Stem Cell Trials
3. UPMC Invests in Intelligent Infrastructure with IBM to Support Vision of Personalized Medicine
4. Chicago Celebrates First Informatics Week, Co-Chaired by Intelligent Medical Objects and Northwestern University
5. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
6. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
7. U.S. Patent Office to Issue 11 Patents for Nyxoahs Sleep Apnea Innovative Implant Technology
8. A Record 125 SynCardia Total Artificial Hearts Implanted by Surgeons Worldwide So Far in 2013
9. Nasseo’s TiArray™ Dental Implant System Receives FDA Approval
10. Over 50% of “Best Heart Hospitals” in U.S. News & World Report Are Certified to Implant the SynCardia Total Artificial Heart
11. Emergent and DiFusion Form Strategic Partnership to Take CleanFuze™ Antimicrobial Implants to Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its annual ... Solutions as number 1,361 in growth for the three years through 2014. Being named ... fastest-growing privately held organizations in the country. , “We are thrilled to make ...
(Date:8/27/2015)... ... August 27, 2015 , ... Proove Biosciences, ... data on the relationship of genetics and hypertension at the International Academy ... in Vancouver, British Columbia, Canada. The event, which boasts an extensive overview of ...
(Date:8/26/2015)... , Aug. 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of foodborne ... present at the Sidoti & Company Emerging Growth Conference ... be held at the New York Marriott Marquis. ... be available through the investor relations section of Roka ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic ... it has received a $1.5M Phase II SBIR ... to further develop its therapeutic agent to reduce ... need in end stage renal disease (ESRD) patients ... National Institute of Diabetes and Digestive and Kidney ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
... Calif., May 18, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... Officer of BioMarin, will present a company update at the ... 25, 2011 at 9:30 a.m. GMT.   Interested ... call via the investor section of the BioMarin website, ...
... Northwest Biotherapeutics (OTC Bulletin Board: NWBO ) ... production of DCVax®-L for brain cancer, for clinical trials ... largest applied research foundation in Europe, with a staff ... others dedicated to practical applications and commercialization of research ...
... presented today show that RAPAFLO(R) (silodosin) significantly reduced ... pain syndrome (CP/CPPS).  In the study presented at ... RAPAFLO(R) also significantly improved urinary symptoms as well ... pelvic pain syndrome (CP/CPPS) is a common condition ...
Cached Biology Technology:BioMarin to Present at the UBS Global Specialty Pharmaceuticals Conference 2Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe 2Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe 3Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe 4Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 2Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 3Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 4Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 5Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome 6
(Date:7/31/2015)... , 31 de julio de 2015 ... (ICG-10,  www.icg-10.org ) del 22 al 25 de octubre ... La conferencia celebra su décimo aniversario este ... convertido en una de las reuniones anuales más influyentes ... es una de las conferencias científicas más dinámicas, entusiastas ...
(Date:7/31/2015)... de 2015 La 10 th International Conference ... de BGI del 22 al 25 de octubre de 2015 en ... año, la conferencia celebra su décimo aniversario. Desde su inauguración ... de las reuniones anuales más influyentes del mundo en el ... dinámicas, entusiastas y mejores a nivel científico. ...
(Date:7/31/2015)... -- The 10 th International Conference on Genomics (ICG-10, ... 2015, in Shenzhen , China ... th anniversary this year. Since its inauguration in 2006, ... meetings in the ,omics, fields, and is one of the ... ICG-10 focuses on recent breakthroughs and advances in ,omics, research ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2
... press release is available in German . ... discovered an unusual regulation of enzymes that catalyze chain ... In the horseradish leaf beetle Phaedon cochleariae ... completely different substances depending on whether it is regulated ...
... OH, February 28, 2013 -- Although the long-term consequences ... have reduced physical education classes to devote more time ... However, there is new evidence that leaving out ... test scores. A new study scheduled for publication ...
... the March issue of GSA Today , seven scientists ... of Leicester, propose a realignment of the terms "geochronology" and ... units of the Geological Time Scale should have a single ... system, which retains both parallel sets of units, with an ...
Cached Biology News:Metal ions regulate terpenoid metabolism in insects 2Metal ions regulate terpenoid metabolism in insects 3Reading, writing, arithmetic, and aerobics -- Evaluating the new 'R' in academic performance 2
Mouse monoclonal [050-04] to C2 ( Abpromise for all tested applications). entrezGeneID: 717 SwissProtID: P06681...
Rabbit polyclonal to Bag5 ( Abpromise for all tested applications). entrezGeneID: 9529 SwissProtID: Q9UL15...
Rabbit polyclonal to Tryptophanyl tRNA synthetase ( Abpromise for all tested applications). Antigen: Recombinant full length protein (Human): Tryptophanyl tRNA synthetase Entrez Gene ID: 745...
WTAP Antibody...
Biology Products: